Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
03/2003
03/20/2003US20030054488 Goodpasture antigen binding protein
03/20/2003US20030054445 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01
03/20/2003US20030054409 Novel complex-forming proteins
03/20/2003US20030054398 Isolated human aminotransferase proteins, nucleic acid molecules encoding aminotransferase proteins and uses thereof
03/20/2003US20030054365 MHC class II antigen presenting cells containing oligonucleotides which inhibit Ii protein expression
03/20/2003US20030054341 Viral nucleotide sequences for use in diagnosis, prevention and treatment of viral diseases
03/20/2003US20030054052 Triterpene compositions and methods for use thereof
03/20/2003US20030054046 Hydrated dressing containing metal microbiocide
03/20/2003US20030054042 Stabilization of chemical compounds using nanoparticulate formulations
03/20/2003US20030054037 Pharmaceutical compositions of adsorbates of amorphous drug
03/20/2003US20030054028 Sustained releasing drug in situ
03/20/2003US20030054013 Tuberculosis therapy; anticancer agents
03/20/2003US20030054011 Anticancer agents
03/20/2003US20030054010 Molecular antigen array
03/20/2003US20030054003 Antitumor agents, anticarcinogenic agents
03/20/2003US20030053990 Virus vectors and methods of making and administering the same
03/20/2003US20030053989 Administering nucleic acid
03/20/2003US20030053984 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins
03/20/2003CA2461692A1 Use of a protein of the crmp family for treating diseases related to the immune system
03/20/2003CA2460348A1 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites
03/20/2003CA2460347A1 3-glyoxlylamideindoles for treating cancer
03/20/2003CA2460345A1 2-aroylimidazole compounds for treating cancer
03/20/2003CA2460331A1 Use of a protein for the production of a medicament for stimulating the innate non-specific immune system
03/20/2003CA2460269A1 Alphavirus replicon vector systems
03/20/2003CA2460092A1 A method of diagnosis and treatment and agents useful for same
03/20/2003CA2460022A1 Aryloxypropylamines as chemosensitizing agent in the treatment of cancer
03/20/2003CA2459886A1 1-glyoxlylamide indolizines for treating cancer
03/20/2003CA2459882A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors
03/20/2003CA2459879A1 3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene)-2-indolinone derivatives as kinase inhibitors
03/20/2003CA2459760A1 Method for preparing unsaturated fatty hydroxy-acids and esters thereof, their use in pharmaceutical and/or cosmetic compositions
03/20/2003CA2459720A1 Source wavelength shifting apparatus and method for delivery of one or more selected emission wavelengths
03/20/2003CA2459373A1 Method of evaluating efficacy of nucleic acid therapy
03/20/2003CA2459318A1 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
03/20/2003CA2459308A1 Cbi analogues of cc-1065 and the duocarmycins
03/20/2003CA2459307A1 Compositions comprising mixtures of therapeutic proteins and methods of producing the same
03/20/2003CA2458543A1 Compositions and methods for treatment of cancer
03/20/2003CA2458302A1 New assay for inhibitors of translocases
03/20/2003CA2458029A1 Methods of treating cytokine mediated diseases
03/20/2003CA2457848A1 Use of 4-pyridylmethylphthalazines for cancer treatment
03/20/2003CA2455990A1 Methods for diagnosing and treating diseases and conditions associated with protein kinase c.lambda.
03/20/2003CA2451454A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003CA2451254A1 Novel proteins and nucleic acids encoding same
03/19/2003EP1293565A2 Mammalian telomerase RNA component
03/19/2003EP1293507A1 Process for producing crystal
03/19/2003EP1293212A1 Anti cancer vaccine comprising whole cancer cells with modified sialic acid
03/19/2003EP1293205A1 Valproic acid and derivatives thereof for the combination therapy of human cancers, for the treatment of tumour metastasis and minimal residual disease
03/19/2003EP1293201A2 Use of aminoadamantane compounds as immunoregulators
03/19/2003EP1292709A1 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
03/19/2003EP1292694A2 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses
03/19/2003EP1292685A2 Human lyases
03/19/2003EP1292684A2 Proteases
03/19/2003EP1292683A2 Secreted redox proteins
03/19/2003EP1292679A1 A g-protein coupled receptor
03/19/2003EP1292678A2 G-protein coupled receptors
03/19/2003EP1292675A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer
03/19/2003EP1292620A2 Nuclear hormone receptor
03/19/2003EP1292619A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation
03/19/2003EP1292597A1 Carbamate and thiocarbamate podophyllotoxin derivatives, preparation method and pharmaceutical compositions containing them
03/19/2003EP1292594A1 Quinazoline derivatives for the treatment of tumours
03/19/2003EP1292591A2 Substituted bicyclic derivatives for the treatment of abnormal cell growth
03/19/2003EP1292579A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
03/19/2003EP1292576A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
03/19/2003EP1292568A2 Benzamide ligands for the thyroid receptor
03/19/2003EP1292562A1 Triterpenoid derivatives
03/19/2003EP1292336A2 Conjugates of aminodrugs comprising an oxime bond
03/19/2003EP1292335A2 Combinations and compositions which interfere with vegf/vegf and angiopoietin/tie receptor function and their use (ii)
03/19/2003EP1292334A1 Bispecific fusion protein and method of use for enhancing effector cell killing of target cells
03/19/2003EP1292321A1 Method to increase class i presentation of exogenous antigens by human dendritic cells
03/19/2003EP1292319A2 Extracts from spermatophyte plants with antitumor activity
03/19/2003EP1292314A2 Method for treating respiratory disorders associated with pulmonary elastic fiber injury comprising the use of glycosaminoglycans
03/19/2003EP1292308A1 Alpha,beta-unsaturated sulfones for treating proliferative disorders
03/19/2003EP1292299A2 New use of citreamicins
03/19/2003EP1292298A1 Intracorporeal medicaments for high energy phototherapeutic treatment of disease
03/19/2003EP1292297A1 Pharmaceutical combination of bicalutamide and anastrozole for providing an anti-androgenic effect and aromatase inhibition
03/19/2003EP1292296A1 Pharmaceutical combination of bicalutamide and tamoxifen for providing an anti-androgenic effect and an anti-oestrogenic effect
03/19/2003EP1292290A2 Pharmaceutical compositions comprising acryloyl distamycin derivatives and topoisomerase i and ii inhibitors
03/19/2003EP1292289A2 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers
03/19/2003EP1292284A2 Encapsulation of polynucleotides and drugs into targeted liposomes
03/19/2003EP1292279A1 The use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
03/19/2003EP1278528A4 Nucleoside analogs with carboxamidine-modified bicyclic base
03/19/2003EP1257281A4 Nucleoside analogs with carboxamidine modified monocyclic base
03/19/2003EP1177195B1 1-AMINO TRIAZOLO 4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV
03/19/2003EP1157019B1 4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular cdk2
03/19/2003EP1149106B1 4,5-azolo-oxindoles
03/19/2003EP1137671B1 Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions
03/19/2003EP1082344B1 Glycoproteins having lipid mobilising properties and therapeutic applications thereof
03/19/2003EP1077980B1 Epothilone derivatives, a method for the production thereof, and their use
03/19/2003EP1056768B1 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
03/19/2003EP0973390A4 Retinoid related molecules for the inhibition of endothelin-1 overproduction in disease
03/19/2003EP0964697B1 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene
03/19/2003EP0952853B1 Conjugate comprising an active agent, a polypeptide and a polyether
03/19/2003EP0910409A4 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens
03/19/2003EP0876482B1 Il-13 receptor polypeptide
03/19/2003EP0874847B1 Novel purine derivatives having, in particular, antiproliferative properties, and biological uses thereof
03/19/2003EP0871490B1 Branched hydrazone linkers
03/19/2003EP0865609B1 Method of diagnosing and treating epithelioma
03/19/2003EP0754035B1 Carotenoid agent for inhibiting the conversion of epithelial cells to melanomas
03/19/2003EP0745094B1 Superagonists and antagonists of human il-6, and method for their selection
03/19/2003EP0736093B1 ANTISENSE NUCLEIC ACIDS FOR THE PREVENTION AND TREATMENT OF DISORDERS IN WHICH EXPRESSION OF c-erbB-2 PLAYS A ROLL
03/19/2003EP0677104B1 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use
1 ... 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 ... 2211